In the 90 days prior to the date of this filing, there have been 9 insider transactions from the activity of one insider all of which have been purchases and resulted in the acquisition of 1,300,000 company shares. Relative to the preceding 90-day window of time, there were 16 transactions from 1 insider which resulted in the acquisition of 985,000 shares.
This is lower than the average level of insider transactions in the 150-company Pharmaceuticals peer group over the last 90-day period. Activity in the peer group averaged 41.0 transactions per company, and disposition of 7,232 shares on average.
SEC Story Link http://www.sec.gov/Archives/edgar/data/944809/000120919119058225/xslF345X03/doc4.xml
|Insider Trends: Pacific Premier Bancorp Insider Conv...|
|Insider Trends: 90-Day Insider Selling Trend Prolong...|
|Insider Trends: Insider Sale Reduces 90-Day Buy Tren...|
|Insider Trends: Insider Sale Eases Back 90-Day Buy T...|
|Insider Trends: Insider Purchase of Zymeworks Stock ...|